| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | US20040077684 Piperidinyl compounds that selectively bind integrins |
| 04/22/2004 | US20040077680 Ureaacylated indazole, benzisoxazole, or benzisothiazole derivative with monocyte chemoattractant protein inhibitors; antiinflammatory agents; autoimmune diseases; arthritis, asthma, atherosclerosis, diabetes |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077664 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 04/22/2004 | US20040077658 Respiratory system, nervous system, brain, gastrointestinal and psychological disorders; chronic obstructive pulmonary disease; antiasthmatics, analgesics |
| 04/22/2004 | US20040077630 Allosteric adenosine receptor modulators |
| 04/22/2004 | US20040077531 Regulating luteotropic hormone secretion; amino acid sequence 35 |
| 04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 04/22/2004 | US20040076986 A gene and/or a protein involved in the prevention or treatment of allergic diseases and dermatitis |
| 04/22/2004 | US20040076956 Oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA repair which are directed against the sequence; ascertaining genetic and/ or epigenetic parameters of DNA repair genes |
| 04/22/2004 | US20040076672 For treating cancer and other angiogenic-dependent diseases, and more specifically, to compositions comprising anti-angiogenic factors and polymeric carriers, stents which have been coated with such compositions |
| 04/22/2004 | US20040076669 Tramadol-based medicament |
| 04/22/2004 | DE10153346A1 Substituierte Indole Substituted indoles |
| 04/22/2004 | CA2501389A1 Remedies or preventives for frequent urination or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
| 04/22/2004 | CA2487854A1 Method for screening an agent for treating renal failure |
| 04/21/2004 | EP1411128A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 04/21/2004 | EP1410822A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 04/21/2004 | EP1410797A1 Solid oral dosage forms comprising valsartan |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 04/21/2004 | EP1409690A2 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
| 04/21/2004 | EP1409644A1 Probiotic bifidobacterium strains |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409531A2 Heterocarpine, a human ghrh-binding protein |
| 04/21/2004 | EP1409513A1 Methylene-4-azasteroids |
| 04/21/2004 | EP1409489A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 04/21/2004 | EP1409487A1 Pteridinones as kinase inhibitors |
| 04/21/2004 | EP1409483A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 04/21/2004 | EP1409481A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 04/21/2004 | EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1409000A4 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 04/21/2004 | EP1409000A1 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 04/21/2004 | EP1408995A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 04/21/2004 | EP1408989A2 Method and material for treating immune diseases |
| 04/21/2004 | EP1408947A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 04/21/2004 | EP1408911A1 Sustained-release therapeutic bioadhesive systems |
| 04/21/2004 | EP1272481B1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 04/21/2004 | EP1124546B1 Use of hyaluronic acid for the treatment of radiation cystitis |
| 04/21/2004 | EP1121099B1 Pharmaceutical composition with gastric residence and controlled release |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491216A Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence |
| 04/21/2004 | CN1491213A Novel benzoylguanidine salt |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1490321A Effective parts of fructus sophorae flavone production and use thereof |
| 04/21/2004 | CN1490311A Bafuluomaidi as alpha No. subacceptor for blocking sympathetic nerve |
| 04/21/2004 | CN1490048A Method for improving oral drug living thing availability, composition and reagent box |
| 04/21/2004 | CN1490020A Oral Chinese patent drug for treating pelvis and nephritis and preparing method thereof |
| 04/21/2004 | CN1146553C Hydroxymatatairesinol in cancer prevention |
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/21/2004 | CN1146414C Amino acid composition and use thereof in immunosuppression |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723741 Benzimidazoles and benzothiazoles and uses thereof |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents |
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | US6723343 Pharmaceutical tramadol salts |
| 04/15/2004 | WO2004031203A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 04/15/2004 | WO2004031177A1 2-aminobenzimidazole derivative |
| 04/15/2004 | WO2004030671A2 Use of 4-amino-quinazolines as anti cancer agents |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | WO2003099845A3 Fas peptide mimetics and uses thereof |
| 04/15/2004 | WO2003088956A8 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide |
| 04/15/2004 | WO2003049717A3 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases |
| 04/15/2004 | WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/15/2004 | WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 04/15/2004 | WO2002069980A3 Pharmaceutically effective ginsenosides and their use |
| 04/15/2004 | WO2002055706A3 Asip-related proteins |
| 04/15/2004 | WO2002043715A3 Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence |
| 04/15/2004 | US20040073958 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072890 Anticancer agents |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 04/15/2004 | US20040072876 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072863 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072851 Incontinence; benign prostatic hyperplasia |
| 04/15/2004 | US20040072850 Caspase inhibitors and uses thereof |
| 04/15/2004 | US20040072846 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 04/15/2004 | US20040072840 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders |
| 04/15/2004 | US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072831 Reverse-turn mimetics and method relating thereto |
| 04/15/2004 | US20040072828 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040072762 Diazocine derivatives and their use as tryptase inhibitors |
| 04/15/2004 | US20040072726 Decoy is an NF- kappa B decoy, an ets decoy, or a chimera decoy of NF- kappa B and ets. The disease is cerebral aneurysm, cancer, aortic detachment, post-angioplasty restenosis, chronic articular rheumatism, asthma, atopic etc. |
| 04/15/2004 | US20040072238 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040071766 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 04/15/2004 | US20040071686 Treatment of alpha-galactosidase A deficiency |
| 04/15/2004 | US20040071677 Nephritis treatment by gene therapy |